New paradigms in mantle cell lymphoma: is it time to risk-stratify treatment based on the proliferative signature? (Q43623431)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | New paradigms in mantle cell lymphoma: is it time to risk-stratify treatment based on the proliferative signature? |
scientific article |
Statements
1 reference
New paradigms in mantle cell lymphoma: is it time to risk-stratify treatment based on the proliferative signature? (English)
1 reference
Martin Dreyling
Niklas Vogt
Wolfram Klapper
European Mantle Cell Lymphoma Network
1 October 2014
1 reference